MedPath

Mesenchymal stem cell injection in patients with knee osteoarthritis compared to a randomized controlled trial

Phase 3
Recruiting
Conditions
Knee osteoarthritic.
Osteoarthritis of knee
M17,
Registration Number
IRCT20210307050611N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Knee Osteoarthritis Based on American College of Rheumatology Criteria in Grades 1, 2, and 3: Lowrence - Kellergan
Knee pain for at least six months
Proper liver function (Bilirubin = 2.0 ?/?, AST/ALT = 100 IU/L)
Proper renal function (Creatinine = 2.0 ?/?)

Exclusion Criteria

Any acute or chronic infection
Pregnancy or decision to become pregnant
Any intra-articular injection during the last three months
Inflammatory joint disease or secondary osteoarthritis
History of knee surgery
Severe underlying disease such as uncontrolled diabetes, taking anticoagulants
Daily use of opioid and non-opioid analgesics

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain: The pain assessment scale is performed by the VAS test. In this questionnaire, which is filled in by the participant before the intervention and six months after the intervention, the least pain in the last trimester is zero and the number 10 is considered as the highest pain in the last trimester. Scores between zero and 10 for the amount of pain. Timepoint: Before intervention and 6 months after injection. Method of measurement: VAS questionnaire.
Secondary Outcome Measures
NameTimeMethod
Pain due to inflammation in the knee joint in the last 6 months. Timepoint: Before the intervention and 6 months later. Method of measurement: The VAS questionnaire is filled out by the patient for the amount of pain and the patient scores from 0 to 10 according to the amount of pain.;The range of motion of the knee joint from the extent position to 140 degrees is measured in both active and passive forms. Timepoint: Before intervention and 6 months after injection. Method of measurement: Goniometer.;Knee cartilage formation using MRI image. Timepoint: Before intervention and 6 months after injection. Method of measurement: MRI image of the knee in a supine position.
© Copyright 2025. All Rights Reserved by MedPath